Exhibit 107
Calculation of Filing Fee Tables
FORM S-3
(Form Type)
APTOSE BIOSCIENCES INC.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| | Security Type | Security Class Title(1) | Fee
Calculation
or Carry
Forward Rule | Amount
Registered | Proposed
Maximum
Offering Price
Per Unit | Maximum
Aggregate
Offering Price | Fee Rate | Amount of
Registration Fee |
| Newly Registered Securities |
| Fees to be Paid | Equity | Common Shares, no par value | 457(o) | (1) | (2) | (1)(2) | $0.0001102 | (1)(2) |
| Fees to be Paid | Other | Warrants | 457(o) | (1) | (2) | (1)(2) | $0.0001102 | (1)(2) |
| Fees to be Paid | Other | Units | 457(o) | (1) | (2) | (1)(2) | $0.0001102 | (1)(2) |
| Fees to be Paid | Unallocated (Universal) Shelf | Unallocated (Universal) Shelf | 457(o) | $200,000,000 (1) | | $200,000,000 (1)(2) | $0.0001102 | $22,040 (1)(2) |
| | Total Offering Amounts | | $200,000,000 | | $22,040 |
| | Total Fees Previously Paid | | | | |
| | Total Fee Offsets | | | | $8,146 |
| | Net Fee Due | | | | $13,894 |
| (1) | There are being registered under this Registration Statement such indeterminate number of common shares, warrants, and units of the Registrant, and a combination of such securities, separately or as units, as may be sold by the registrant from time to time, which collectively shall have an aggregate initial offering price not to exceed US$200,000,000. The securities registered hereunder also include such indeterminate number of each class of identified securities as may be issued upon conversion, exercise or exchange of any other securities that provide for such conversion into, exercise for or exchange into such securities. Separate consideration may or may not be received for securities that are issuable on exercise, conversion or exchange of other securities. In addition, pursuant to Rule 416 under the Securities Act of 1933 (the “Securities Act”), as amended, the common shares being registered hereunder include such indeterminate number of common shares as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends, or similar transactions. The proposed maximum initial offering price per security will be determined, from time to time, by the registrant in connection with the sale of the securities under this Registration Statement. |
| (2) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) of the Securities Act. |
Table 2: Fee Offset Claims and Sources
| | Registrant or Filer Name | Form or Filing Type | File Number | Initial Filing Date | Filing Date | Fee Offset Claimed | Security Type Associated with Fee Offset Claimed | Security Title Associated with Fee Offset Claimed | Unsold Securities Associated with Fee Offset Claimed | Unsold Aggregate Offering Amount Associated with Fee Offset Claimed | Fee Paid with Fee Offset Source |
| | Rule 457(p) |
| Fees Offset Claims | Aptose Biosciences Inc. | S-3 | 333-235730(3) | 12/27/2019 | | $8,146 | Unallocated (Universal) Shelf | Unallocated (Universal) Shelf | Unallocated (Universal) Shelf | $62,764,022 | |
| Fees Offset Sources | Aptose Biosciences Inc. | S-3 | 333-235730(3) | | 12/27/2019 | | | | | | $8,146 |
| | | | | | | | | | | | |
| (3) | Attributable to US$62,764,022 of unsold securities (US$8,146 of previously paid fees) that were previously registered under the Registration Statement on Form S-3 (333-235730) on December 27, 2019 (the “Prior Registration Statement”) that have not yet been issued and sold. Pursuant to Rule 457(p) under the Securities Act, such unutilized filing fees may be applied to the filing fees payable pursuant to this Registration Statement, and the Prior Registration Statement and the offering of the unsold securities registered under the Prior Registration Statement will be deemed terminated as of the effective date of this Registration Statement. |
